European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Brunel University London Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Sheffield Featured PhD Programmes

PhD in Dementia Research - Molecular mechanisms of CRISPR Cas9 nickase-induced CAG/CTG repeat contraction: implications for gene editing in expanded repeat disorders

Project Description

Expanded CAG/CTG repeats cause 14 clinically different neurological, neuromuscular, and neurodegenerative diseases, including Huntington’s disease and myotonic dystrophy. There is currently no way of curing these diseases or even of slowing their progression. The repeats are highly unstable, with changes in size occurring in every cell for some organs. The instability phenomenon alters the phenotypic outcome, with longer repeats generally leading to more severe phenotypes. Thus, an attractive therapeutic possibility is to shrink repeats down to a normal size.
We have recently developed the first way to contract repeat tracts at high efficiencies (Cinesi et al, Nat Comms 2016). The method relies on using the CRISPR/Cas9 nickase and the results have important implications in designing a treatment for these devastating diseases. Indeed, targeting the Cas9 nickase to expanded CAG/CTG repeats leads to efficient contractions in a reporter system as well as in cells derived from patients with myotonic dystrophy, effectively correcting the mutation. Importantly, we could not detect off-target mutations, making this approach especially attractive.
Gap in knowledge:
How the CRISPR/Cas9 nickase provokes CAG/CTG repeat contractions is unknown.
Goal of the project:
Here we aim to understand how contractions occur at the molecular level such that we can make a potential gene editing-based treatment safer and more efficient.
The project will use a combination of molecular biology, genome engineering, genetics, and high throughput sequencing to uncover genetic interactors and map the network leading to nickase-induced contractions. For this, we will use our reporter system, which is ideal for screening. Next, we will apply the knowledge gained to improve the efficiency of contractions using Huntington’s disease patient-derived induced pluripotent stem cells as a model of the disease. We will further estimate the frequencies of the off-target mutations induced by the CRISPR/Cas9 nickase using next-generation sequencing. Finally, we will assay whether the cellular phenotypes of the disease are affected by the presence of contractions.
The CRISPR/Cas9 technology is already used in about 25 different clinical trials. It therefore holds great promise for the treatment of a wide variety of diseases. Defining the mechanism of contractions induced by the Cas9 nickase will bring us a step closer to the clinic by potentially making the treatment safer, more specific, and more efficient. The knowledge uncovered here could also help identify patients who would respond either poorly or particularly well to a Cas9 nickase-based treatment.
Both Vincent Dion and Nick Allen have a track record of graduating students on time and of supporting their intellectual, technical, and scientific growth.
Cinzia Cinesi, Lorène Aeschbach, Bin Yang & Vincent Dion. Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase. Nature Communications 7 ; 13272 (2016).

Funding Notes

The funding for the studentship is provided by the UK Dementia Research Institute at Cardiff. Funding is in competition with 5 projects advertised, and an anticipation to fund 3.
Full UK/EU tuition fees
Doctoral stipend matching UK Research Council National Minimum.
Additional funding is available over the course of the programme and will cover costs such as research consumables and training.

Applicants should possess a minimum of an upper second class Honours degree, master's degree, or equivalent in a relevant subject.
Applicants whose first language is not English are normally expected to meet the minimum University requirements (e.g. 6.5 IELTS)


The duration of the PhD will be 3.5 years
In order to be considered you must submit a formal application via Cardiff University’s online application service. (To access the system click 'Apply Online' at the bottom of this advert)
There is a box at the top right of the page labelled ‘Apply’, please ensure you select the correct ‘Qualification’ (Doctor of Philosophy), the correct ‘Mode of Study’ (Full Time) and the correct ‘Start Date’ (October 2019). This will take you to the application portal.
In order to be considered candidates must submit the following information:

• Supporting statement
• CV
• Qualification certificates
• References x 2 (references are optional but will strengthen your application)
• Proof of English language (if applicable)

In the 'Research proposal and Funding' section of your application, please specify the project title and supervisors of the project and copy the project description in the text box provided.
Please select 'No, I am not self-funding my research' when asked whether you are self-funding your research.
In the funding section, please select "I will be applying for a scholarship / grant" and specify that you are applying for advertised funding from UK DRI.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2019
All rights reserved.